These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Efficacy of different beta-blockers in the treatment of long QT syndrome. Abu-Zeitone A, Peterson DR, Polonsky B, McNitt S, Moss AJ. J Am Coll Cardiol; 2014 Sep 30; 64(13):1352-8. PubMed ID: 25257637 [Abstract] [Full Text] [Related]
12. Effects of cohort, genotype, variant, and maternal β-blocker treatment on foetal heart rate predictors of inherited long QT syndrome. Kaizer AM, Winbo A, Clur SB, Etheridge SP, Ackerman MJ, Horigome H, Herberg U, Dagradi F, Spazzolini C, Killen SAS, Wacker-Gussmann A, Wilde AAM, Sinkovskaya E, Abuhamad A, Torchio M, Ng CA, Rydberg A, Schwartz PJ, Cuneo BF. Europace; 2023 Nov 02; 25(11):. PubMed ID: 37975542 [Abstract] [Full Text] [Related]
15. Value of the "Standing Test" in the Diagnosis and Evaluation of Beta-blocker Therapy Response in Long QT Syndrome. Muñoz-Esparza C, Zorio E, Domingo Valero D, Peñafiel-Verdú P, Sánchez-Muñoz JJ, García-Molina E, Sabater M, Navarro M, San-Román I, Pérez I, Santos JJ, Cabañas-Perianes V, Valdés M, Pascual D, García-Alberola A, Gimeno Blanes JR. Rev Esp Cardiol (Engl Ed); 2017 Nov 02; 70(11):907-914. PubMed ID: 28233664 [Abstract] [Full Text] [Related]
20. Additional gene variants reduce effectiveness of beta-blockers in the LQT1 form of long QT syndrome. Kobori A, Sarai N, Shimizu W, Nakamura Y, Murakami Y, Makiyama T, Ohno S, Takenaka K, Ninomiya T, Fujiwara Y, Matsuoka S, Takano M, Noma A, Kita T, Horie M. J Cardiovasc Electrophysiol; 2004 Feb 02; 15(2):190-9. PubMed ID: 15028050 [Abstract] [Full Text] [Related] Page: [Next] [New Search]